Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Forty patients with Hodgkin lymphoma underwent an allogeneic stem cell transplant with the gemcitabine-fludarabine-melphalan reduced-intensity conditioning regimen. The median age was 31 years (range 20–63). Thirty-one (77%) had undergone a prior autologous stem cell transplant, and the median time...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Plair, Tamera, Alousi, Amin M., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Popat, Uday R., Shpall, Elizabeth J, Fanale, Michelle A., Hagemeister, Frederick B., Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E., Younes, Anas, Champlin, Richard E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193224/
https://ncbi.nlm.nih.gov/pubmed/27064056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.03.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados